89 related articles for article (PubMed ID: 1834847)
1. The unique binding properties of amlodipine: a long-acting calcium antagonist.
Nayler WG; Gu XH
J Hum Hypertens; 1991 Aug; 5 Suppl 1():55-9. PubMed ID: 1834847
[TBL] [Abstract][Full Text] [Related]
2. (-)[3H]amlodipine binding to rat cardiac membranes.
Nayler WG; Gu XH
J Cardiovasc Pharmacol; 1991 Apr; 17(4):587-92. PubMed ID: 1711625
[TBL] [Abstract][Full Text] [Related]
3. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
4. Vascular and myocardial effects of amlodipine: an overview.
Nayler WG; Gu XH
Postgrad Med J; 1991; 67 Suppl 5():S41-3. PubMed ID: 1839439
[TBL] [Abstract][Full Text] [Related]
5. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
6. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
7. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites.
Ishii A; Nishida K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
[TBL] [Abstract][Full Text] [Related]
9. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Mason RP; Moisey DM; Shajenko L
Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
[TBL] [Abstract][Full Text] [Related]
11. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
Zobrist RH; Mecca TE
J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
13. Residual inhibition in density of [3H]isradipine binding sites in rat brain membrane pretreated with amlodipine.
Qu YL; Takamizawa C; Sugiyama K; Maruyama K; Hattori K; Watanabe K; Nagatomo T
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):289-93. PubMed ID: 7668092
[TBL] [Abstract][Full Text] [Related]
14. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
Rampe D; Poder T; Zhao ZY; Schilling WP
J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.
Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H
Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252
[TBL] [Abstract][Full Text] [Related]
17. Binding properties of (+/-)[3H]benidipine hydrochloride to rat heart membranes.
Ishii A; Toyama J
J Cardiovasc Pharmacol; 1993 Feb; 21(2):191-6. PubMed ID: 7679151
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine: a once daily calcium antagonist.
Burges RA
J Hum Hypertens; 1991 Aug; 5 Suppl 1():49-54. PubMed ID: 1834846
[TBL] [Abstract][Full Text] [Related]
19. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
20. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
Liu J; Bangalore R; Rutledge A; Triggle DJ
Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
